CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma

DOI:10.1016/j.canlet.2024.216935
作者：Feifan Yao ,?Suiqing Zhou ,?Ruizhi Zhang ,?Yining Chen ,?Wei Huang ,?Kai Yu ,?Nanmu Yang ,?Xiangjun Qian ,?Xiaofeng Tie ,?Jiali Xu ,?Yu Zhang ,?Tasiken Baheti ,?Jing Xu ,?Xinzheng Dai ,?Xiaopei Hao ,?
文献类型：期刊论文
补充材料：只需要正文